Soleno Therapeutics enters $150M at-the-market equity offering with Jefferies

SOLENO THERAPEUTICS INC

Soleno may sell up to $150M of common stock from time to time under Sale Agreement with Jefferies.
Jefferies will use commercially reasonable efforts to sell shares as an at-the-market offering.
Commission of 3.0% of gross proceeds; Soleno also reimburses certain expenses.
Offering made under existing S-3ASR registration statement filed on Jan 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.